James Renwick McCullough

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
London, United Kingdom
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Katie Kazem, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for James Renwick McCullough

Form 4 holding Chief Executive Officer, Director

Renalytix plc

Security class
Ordinary Shares
Shares / value
2,554,398
Estimated value
$638,600
Report date
01 Jul 2023
Price
$0.2500
Ownership
By The McCullough 2020 Irrevocable Trust
Form 4 holding Chief Executive Officer, Director

Renalytix plc

Security class
Ordinary Shares
Shares / value
191,988
Estimated value
$47,997
Report date
01 Jul 2023
Price
$0.2500
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

Renalytix plc

Security class
Employee Stock Option (right to buy)
Shares / value
875,017
Estimated value
Report date
06 Jul 2023
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by James Renwick McCullough

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .